Leadership & People
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: New Chief Medical Officers At Biophytis, Eloxx And La Jolla
New chief financial officers at Alector, CanSino, and more.
Executives On The Move: New CEOs At BerGenBio, Civetta, Jubilant And More
Novartis gets new People And Organization Officer, plus new CEOs at BerGenBio, Pillar Biosciences, Pascal Biosciences, Jubilant and Civetta Therapeutics.
Pharma On Its Back Foot As US Drug Price Reform Advances
Big pharma leaders warn of steep cuts to R&D and US jobs if US drug pricing reform legislation paves the way for direct government price negotiations.
Executives On The Move: New Chief Business Innovation Officer For Pfizer
Aamir Malik leaves McKinsey & Co to join Pfizer as chief business innovation officer and executive vice president.
End Of An Era As Galapagos CEO Van De Stolpe Retires
Some 22 years after founding what was one of the biggest success stories in Europe's biotech sector before a recent series of setbacks in the clinic struck, Onno van de Stolpe has decided to retire as Galapagos CEO and the search has already started for his successor.
Executives On The Move: New CMOs at Bone Therapeutics, Xenon Pharmaceuticals & Novan
Former Tmunity Therapeutics CFO Simona King joins Passage Bio as CFO. Rune Skeie, CFO of BerGenBio, holds the fort as interim CEO until Martin Olin joins in September.
J&J CEO Gorsky Handing Over The Reins To Vice Chairman Duato
Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.
Executives On The Move: New Chief Financial Officers At Novavax, Yumanity
Adagene gets new chief medical officer, while Corcept Therapeutics gets new chief development officer from Gilead.
Musical Chairs: Lilly Leadership Changes Underscore Confidence In Donanemab Accelerated Approval
Oncology leader Anne White will oversee neuroscience and pain, while Bio-Medicines head Ilya Yuffa will take over for retiring Lilly International president; Loxo CEO will oversee entire oncology business.
Executives On The Move: New CEO At Stelis Biopharma, NuCana Picks Up Chief Medical Officer
New chief financial officers at Quiapeg Pharmaceuticals and Trevi Therapeutics.
Cautious Optimism For Alzheimer's Mounts Among Industry R&D Leaders
Some big pharma R&D leaders have signaled enhanced interest in neuroscience R&D – and Alzheimer's more specifically – following FDA's approval of Biogen's Aduhelm based on biomarkers.
Executives On The Move: New Chief Financial Officers At AstraZeneca, Cyxone
New chief medical officers at IGM Biosciences, Compass Pathways, Passage Bio and more.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.